Induced sputum and airway inflammation in asthma and COPD Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment Year: 2006
Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma Source: Eur Respir J 2001; 18: 444-450 Year: 2001
The association between airway hyperresponsiveness to mannitol and T2 inflammatory markers in asthma versus COPD Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD Year: 2020
Disconnect between sputum neutrophils and other measures of airway inflammation in asthma Source: Eur Respir J 2014; 43: 627-629 Year: 2013
Sputum analysis reveals eosinophilic inflammation in difficult-to-control asthma patients with low blood eosinophils and FENO. Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020
Galectn-3 : marker of airway inflammation in bronchial asthma Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018
Increasing sputum basophils is a marker for eosinophil-dominant airway inflammation in adult asthma Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018
Monitoring asthma in children: lung function, bronchial hyperresponsiveness and inflammation Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force Year: 2014
Mechanisms of noneosinophilic asthma Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007
Cysteinyl-leukotriene levels in sputum differentiate asthma from rhinitis patients with or without bronchial hyperresponsiveness Source: Annual Congress 2007 - Asthma subphenotypes Year: 2007
Smoking effect on airways inflammation in asthma and COPD: relationship with airways reversibility and hyperresponsiveness Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009
Sputum eosinophilia, airway hyperresponsiveness and airway narrowing in young adults with former asthma Source: Eur Respir J 2005; 26: Suppl. 49, 733s Year: 2005
Eosinophilic inflammation in sputum of poorly controlled asthmatics Source: Eur Respir J 2002; 20: 1370-1377 Year: 2002
Changes in lung functions and inflammatory markers in induced sputum of patients with bronchial asthma and allergic rhinitis in relation to exposure to pollen allergens Source: Eur Respir J 2005; 26: Suppl. 49, 734s Year: 2005
IPL576,092 reduces allergen-induced late asthmatic responses, sputum eosinophilia and airway hyperresponsiveness in mild asthma Source: Eur Respir J 2003; 22: Suppl. 45, 104s Year: 2003
Time domain and flow indices of bronchial hyperresponsiveness: association with asthma symptoms, atopy and smoking Source: Eur Respir J 2002; 20: 86-91 Year: 2002
Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD Source: Eur Respir J 2012; 40: 1098-1105 Year: 2012
Exhaled markers in the monitoring of airways inflammation in mild persistent asthma Source: Eur Respir J 2004; 24: Suppl. 48, 679s Year: 2004
Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002